Literature DB >> 18611606

The concentration of sparfloxacin in lung tissues after single and multiple oral doses.

D Honeybourne1, I Greaves, D R Baldwin, J M Andrews, M Harris, R Wise.   

Abstract

The levels of sparfloxacin were measured in serum, alveolar macrophages, epithelial lining fluid (ELF) and bronchial mucosa after single and multiple oral doses. Measurement was performed using a microbiological assay technique. There were 21 subjects in the single dose and 10 subjects in the multiple dose groups. Following a single 400 mg dose of sparfloxacin the mean levels after 11-15 h were 1.2 mg/l in serum, 61.3 mg/l in macrophages, 9.8 mg/l in ELF and 2.6 mg/kg in mucosa. After multiple dosing of 400 mg on day 1 followed by 200 mg daily for the next 2 days the mean levels were 1.2 mg/l in serum, 53.7 mg/l in macrophages, 15.0 mg/l in ELF and 4.4 mg/kg in mucosa. These data predict good clinical efficacy in respiratory tract infections.

Entities:  

Year:  1994        PMID: 18611606     DOI: 10.1016/0924-8579(94)90004-3

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  3 in total

Review 1.  Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.

Authors:  Keith A Rodvold; Jomy M George; Liz Yoo
Journal:  Clin Pharmacokinet       Date:  2011-10       Impact factor: 6.447

2.  Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studies.

Authors:  G G Grassi; I Brumpt
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 3.  Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.

Authors:  K L Goa; H M Bryson; A Markham
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.